Literature DB >> 2079835

Beta-mannosidase deficiency: heterogeneous manifestation in the first female patient and her brother.

W J Kleijer1, P Hu, R Thoomes, M Boer, J G Huijmans, W Blom, O P Van Diggelen, E Seemanova, M Macek.   

Abstract

beta-Mannosidase deficiency was demonstrated in fibroblasts of a girl who showed severe psychomotor retardation, bone deformities and gargoylism and recurrent skin and respiratory infections and who died at 20 years of age from bronchopneumonia. This first demonstration of a female patient confirms the autosomal recessive inheritance of beta-mannosidosis. Further investigation of this gypsy family revealed beta-mannosidosis in an older brother with a milder manifestation of gargoyl facial dysmorphology, mental retardation, hearing impairment and recurrent infections. beta-Mannosidase activity was completely deficient in his cultured skin fibroblasts, leukocytes and plasma. In urine a characteristic disaccharide was present. Heterozygote levels of beta-mannosidase were found in fibroblasts and/or plasma of the parents and one sister.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079835     DOI: 10.1007/BF01800211

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Human beta-mannosidase deficiency.

Authors:  D A Wenger; E Sujansky; P V Fennessey; J N Thompson
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

2.  Human beta-mannosidase deficiency.

Authors:  A Cooper; I B Sardharwalla; M M Roberts
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

3.  Beta-mannosidosis in two brothers with hearing loss.

Authors:  L Dorland; M Duran; F E Hoefnagels; J N Breg; H Fabery de Jonge; K Cransberg; F J van Sprang; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  Alpha- and beta-mannosidoses.

Authors:  A Cooper; C E Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Thin-layer chromatography of oligosaccharides in urine as a rapid indication for the diagnosis of lysosomal acid maltase deficiency (Pompe's disease).

Authors:  W Blom; J C Luteyn; H H Kelholt-Dijkman; J G Huijmans; M C Loonen
Journal:  Clin Chim Acta       Date:  1983-10-31       Impact factor: 3.786

6.  beta-Mannosidase in human leukocytes and fibroblasts.

Authors:  R S Panday; O P van Diggelen; W J Kleijer; M F Niermeijer
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Distribution of central nervous system lesions in beta-mannosidosis.

Authors:  K L Lovell; M Z Jones
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase.

Authors:  M Z Jones; G Dawson
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

9.  Human beta-mannosidase deficiency: biochemical findings in plasma, fibroblasts, white cells and urine.

Authors:  A Cooper; C Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

  9 in total
  10 in total

1.  Animal model of human disease. Bovine beta-mannosidosis.

Authors:  M Z Jones; B Abbitt
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

2.  Complementation studies in human and caprine beta-mannosidosis.

Authors:  P Hu; D A Wenger; O P van Diggelen; W J Kleijer
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Bovine kidney beta-mannosidase: purification and characterization.

Authors:  B L Sopher; C E Traviss; K T Cavanagh; M Z Jones; K H Friderici
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

4.  Mutations in four glycosyl hydrolases reveal a highly coordinated pathway for rhodopsin biosynthesis and N-glycan trimming in Drosophila melanogaster.

Authors:  Erica E Rosenbaum; Eva Vasiljevic; Kimberley S Brehm; Nansi Jo Colley
Journal:  PLoS Genet       Date:  2014-05-01       Impact factor: 5.917

5.  Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis.

Authors:  Troy C Lund; Weston P Miller; Julie B Eisengart; Katrina Simmons; Laura Pollard; Deborah L Renaud; David A Wenger; Marc C Patterson; Paul J Orchard
Journal:  Mol Genet Genomic Med       Date:  2019-05-21       Impact factor: 2.183

6.  Oral manifestation and dental treatment of pediatric patient with beta-mannosidosis: A case report.

Authors:  Mohammad A Alshoraim; Dania E Al Agili
Journal:  SAGE Open Med Case Rep       Date:  2021-12-15

7.  Impact of Multiple Sclerosis Risk Polymorphism rs7665090 on MANBA Activity, Lysosomal Endocytosis, and Lymphocyte Activation.

Authors:  Adela González-Jiménez; Pilar López-Cotarelo; Teresa Agudo-Jiménez; Ignacio Casanova; Carlos López de Silanes; Ángeles Martín-Requero; Fuencisla Matesanz; Elena Urcelay; Laura Espino-Paisán
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

8.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

9.  Beta-mannosidae deficiency in two mentally retarded girls with intractable seizures.

Authors:  Mathew Punnachalil Cherian
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

10.  Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.

Authors:  Dana Safka Brozkova; Lukas Varga; Anna Uhrova Meszarosova; Zuzana Slobodova; Martina Skopkova; Andrea Soltysova; Andrej Ficek; Jan Jencik; Jana Lastuvkova; Daniela Gasperikova; Pavel Seeman
Journal:  Orphanet J Rare Dis       Date:  2020-08-26       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.